Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 May 19;14(10):2500.
doi: 10.3390/cancers14102500.

Fertility after Cancer: Risks and Successes

Chiara Di Tucci  1 , Giulia Galati  1 , Giulia Mattei  1 , Alessandra Chinè  1 , Alice Fracassi  1 , Ludovico Muzii  1
Affiliations
Review

Fertility after Cancer: Risks and Successes

Chiara Di Tucci et al. Cancers (Basel). .

Abstract

The incidence of cancer in reproductive-aged women is 7%, but, despite the increased number of cancer cases, advances in early diagnosis and treatment have raised the survival rate. Furthermore, in the last four decades, there has been a rising trend of delaying childbearing. There has been an increasing number of couples referred to Reproductive Medicine Centers for infertility problems after one partner has been treated for cancer. In these cases, the main cause of reduced fertility derives from treatments. In this review, we describe the effects and the risks of chemotherapy, radiotherapy, and surgery in women with cancer, and we will focus on available fertility preservation techniques and their efficacy in terms of success in pregnancy and live birth rates.

Keywords: fertility sparing treatments; gynecologic cancers; infertility; ovarian damage.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Fertility Preservation Options.
See this image and copyright information in PMC

References

    1. You L., Lv Z., Li C., Ye W., Zhou Y., Jin J., Han Q. Worldwide cancer statistics of adolescents and young adults in 2019: A systematic analysis of the Global Burden of Disease Study 2019. ESMO Open. 2021;6:100255. doi: 10.1016/j.esmoop.2021.100255. - DOI - PMC - PubMed
    1. Mahajan N. Fertility preservation in female cancer patients: An overview. J. Hum. Reprod. Sci. 2015;8:3–13. doi: 10.4103/0974-1208.153119. - DOI - PMC - PubMed
    1. Rossi L., Mazzara C., Pagani O. Diagnosis and Treatment of Breast Cancer in Young Women. Curr. Treat. Options Oncol. 2019;20:86. doi: 10.1007/s11864-019-0685-7. - DOI - PubMed
    1. Francis P.A., Regan M.M., Fleming G.F., Láng I., Ciruelos E., Bellet M., Bonnefoi H.R., Climent M.A., Da Prada G.A., Burstein H.J., et al. Adjuvant ovarian suppression in premenopausal breast cancer. N. Engl. J. Med. 2015;372:436–446. doi: 10.1056/NEJMoa1412379. - DOI - PMC - PubMed
    1. Smallridge R.C., Copland J.A. Anaplastic thyroid carcinoma: Pathogenesis and emerging therapies. Clin. Oncol. 2010;22:486–497. doi: 10.1016/j.clon.2010.03.013. - DOI - PMC - PubMed

LinkOut - more resources